COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
Line 25: Line 25:
'''Dermatologic Disorders of COVID-19 Team Members'''
'''Dermatologic Disorders of COVID-19 Team Members'''
*'''[[User:Aditya Ganti|Aditya Ganti, M.B.B.S.]]'''
*'''[[User:Aditya Ganti|Aditya Ganti, M.B.B.S.]]'''
*[[user:Nuha|Nuha AL-Howthi, MD]]
*[[user:Dr.Nuha|Nuha AL-Howthi, MD]]
*[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]]
*[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]]


Line 34: Line 34:
*[[User:Sara Haddadi|Sara Haddadi, M.D.]]
*[[User:Sara Haddadi|Sara Haddadi, M.D.]]
* [[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
* [[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
* [[user:Nuha|Nuha AL-Howthi, MD]]
* [[user:Dr.Nuha|Nuha AL-Howthi, MD]]
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
* [[Ogechukwu Hannah Nnabude, MD]]
* [[Ogechukwu Hannah Nnabude, MD]]

Revision as of 20:03, 22 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members

Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members